Abstract
Inflammatory bowel disease (IBD), with Crohn’s disease and ulcerative colitis as main subtypes, is a prototypical multifactorial disease with both genetic and environmental factors involved. Genetically, IBD covers a wide spectrum from monogenic to polygenic forms. In polygenic disease, many genetic variants each contribute a small amount to disease risk. With the advent of genome-wide association studies (GWAS), it became possible to find these variants and corresponding genes, leading so far to the discovery of ca 240 loci associated with IBD. Together, these however explain only 20–25% of the heritability of IBD, leaving a large portion unaccounted for. This missing heritability might be hidden in common variants with even lower effect than the ones currently found through GWAS, but also in rare variants which can be found through large-scale sequencing studies or potentially in multiplex families. In this review, we will give an overview of the current knowledge about the genetics of non-monogenic IBD and how it differs from the monogenic form(s), and future perspectives. The history of IBD genetic studies from twin studies over linkage studies to GWAS, and finally large-scale sequencing studies and the revisiting of multiplex families will be discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
This is an example plot that is not based on real data. Values were created with the statistics program R to make this plot. The only purpose of this data was to construct this plot and does not have any meaning.
References
Abreu MT, Taylor KD, Lin Y-C et al (2002) Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn’s disease. Gastroenterology 123:679–688. https://doi.org/10.1053/gast.2002.35393
Agarwala V, Flannick J, Sunyaev S, Altshuler D (2013) Evaluating empirical bounds on complex disease genetic architecture. Nat Genet 45:1418–1427. https://doi.org/10.1038/NG.2804
Anderson CA, Boucher G, Lees CW et al (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43:246–252. https://doi.org/10.1038/NG.764
Annese V, Piepoli A, Latiano A et al (2005) HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Dis Colon Rectum 48:57–64. https://doi.org/10.1007/s10350-004-0747-0
Babb De Villiers C, Kroese M, Moorthie S (2020) Understanding polygenic models, their development and the potential application of polygenic scores in healthcare. J Med Genet 57:725–732. https://doi.org/10.1136/JMEDGENET-2019-106763
Barrett JC, Hansoul S, Nicolae DL et al (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 40:955–962. https://doi.org/10.1038/NG.175
Barrett JC, Lee JC, Lees CW et al (2009) Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 41:1330–1334. https://doi.org/10.1038/NG.483
Borren NZ, Conway G, Garber JJ et al (2018) Differences in clinical course, genetics, and the microbiome between familial and sporadic inflammatory bowel diseases. J Crohn’s Colitis 12:525–531. https://doi.org/10.1093/ECCO-JCC/JJX154
Bouma G, Oudkerk Pool M, Crusius JB et al (1997) Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn’s disease (CD). Clin Exp Immunol 109:175–179. https://doi.org/10.1046/j.1365-2249.1997.4121510.x
Brant SR, Okou DT, Simpson CL et al (2017) Genome-wide association study identifies african-specific susceptibility loci in African Americans with inflammatory bowel disease. Gastroenterology 152:206-217.e2. https://doi.org/10.1053/J.GASTRO.2016.09.032
Brant SR, Picco MF, Achkar J-P et al (2003) Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn’s disease phenotypes. Inflamm Bowel Dis 9:281–289. https://doi.org/10.1097/00054725-200309000-00001
Burton PR, Clayton DG, Cardon LR et al (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 447:661–678. https://doi.org/10.1038/NATURE05911
Cardon LR, Bell JI (2001) Association study designs for complex diseases. Nat Rev Genet 2:91–99. https://doi.org/10.1038/35052543
Cavanaugh JA, Bryce ME, Stanford PM et al (2001) International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am J Hum Genet 68:1165–1171. https://doi.org/10.1086/320119
Chatterjee N, Wheeler B, Sampson J et al (2013) Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nature Genet 45(4):400–405. https://doi.org/10.1038/ng.2579
Chen G-B, Lee SH, Brion M-JA et al (2014) Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data. Hum Mol Genet 23:4710–4720. https://doi.org/10.1093/HMG/DDU174
Chen G-B, Lee SH, Montgomery GW et al (2017) Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method. BMC Med Genet. https://doi.org/10.1186/S12881-017-0451-2
Choi SW, Mak TS-H, O’Reilly PF (2020) Tutorial: a guide to performing polygenic risk score analyses. Nature Protoc 15(9):2759–2772. https://doi.org/10.1038/s41596-020-0353-1
Cleynen I, Boucher G, Jostins L et al (2016) Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet (london, England) 387:156–167. https://doi.org/10.1016/S0140-6736(15)00465-1
Cleynen I, González JR, Figueroa C et al (2013) Genetic factors conferring an increased susceptibility to develop Crohn’s disease also influence disease phenotype: results from the IBDchip European Project. Gut 62:1556–1565. https://doi.org/10.1136/gutjnl-2011-300777
Cleynen I, Halfvarsson J (2019) How to approach understanding complex trait genetics - inflammatory bowel disease as a model complex trait. Unit Europ Gastroenterol J 7:1426–1430. https://doi.org/10.1177/2050640619891120
Cleynen I, Vermeire S (2015) The genetic architecture of inflammatory bowel disease: past, present and future. Curr Opin Gastroenterol 31:456–463. https://doi.org/10.1097/MOG.0000000000000215
Crowley E, Warner N, Pan J et al (2020) Prevalence and clinical features of inflammatory bowel diseases associated with monogenic variants, identified by whole-exome sequencing in 1000 children at a single center. Gastroenterology 158:2208–2220. https://doi.org/10.1053/J.GASTRO.2020.02.023
Cuthbert AP, Fisher SA, Mirza MM et al (2002) The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122:867–874. https://doi.org/10.1053/gast.2002.32415
de Lange KM, Moutsianas L, Lee JC et al (2017) Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet 49:256–261. https://doi.org/10.1038/NG.3760
DeLisi LE (2016) A case for returning to multiplex families for further understanding the heritability of schizophrenia: a psychiatrist’s perspective. Mole Neuropsychiatry 2:15–19. https://doi.org/10.1159/000442820
Duerr RH, Taylor KD, Brant SR et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (new York, NY) 314:1461–1463. https://doi.org/10.1126/SCIENCE.1135245
Ellinghaus D, Zhang H, Zeissig S et al (2013) Association between variants of PRDM1 and NDP52 and Crohn’s disease, based on exome sequencing and functional studies. Gastroenterology 145:339–347. https://doi.org/10.1053/J.GASTRO.2013.04.040
Frade-Proud’hon-Clerc S, Smol T, Frenois F et al (2019) A novel rare missense variation of the NOD2 gene: evidencesof implication in crohn’s disease. Intern J Mole Sci. https://doi.org/10.3390/IJMS20040835
Franke A, McGovern DPB, Barrett JC et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet 42:1118–1125. https://doi.org/10.1038/NG.717
Freeman HJ (2014) Natural history and long-term clinical course of Crohn’s disease. World J Gastroenterol 20:31–36. https://doi.org/10.3748/WJG.V20.I1.31
Gomollón F, Dignass A, Annese V et al (2017) 3rd European evidence-based consensus on the diagnosis and management of crohn’s disease 2016: part 1: diagnosis and medical management. J Crohn’s Colitis 11:3–25. https://doi.org/10.1093/ECCO-JCC/JJW168
Guan Q (2019) A Comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res. https://doi.org/10.1155/2019/7247238
Hampe J, Franke A, Rosenstiel P et al (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39:207–211. https://doi.org/10.1038/NG1954
Hampe J, Grebe J, Nikolaus S et al (2002) Association of NOD2 (CARD 15) genotype with clinical course of Crohn’s disease: a cohort study. Lancet 359:1661–1665. https://doi.org/10.1016/S0140-6736(02)08590-2
Hong M, Ye BD, Yang SK et al (2018) Immunochip meta-analysis of inflammatory bowel disease identifies three novel loci and four novel associations in previously reported loci. J Crohn’s Colitis 12:730–741. https://doi.org/10.1093/ECCO-JCC/JJY002
Huang H, Fang M, Jostins L et al (2017) Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature 547:173–178. https://doi.org/10.1038/NATURE22969
Hübenthal M, Löscher B-S, Erdmann J et al (2021) Current developments of clinical sequencing and the clinical utility of polygenic risk scores in inflammatory diseases. Front Immunol. https://doi.org/10.3389/FIMMU.2020.577677
Hugot JP, Chamaillard M, Zouali H et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603. https://doi.org/10.1038/35079107
Hugot J-P, Laurent-Puig P, Gower-Rousseaut C et al (1996) Mapping of a susceptibility locus for Crohn’s disease on chromosome. Nature 379:821
Hunt KA, Mistry V, Bockett NA et al (2013) Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature 498:232–235. https://doi.org/10.1038/NATURE12170
Jezernik G, Mičetić-Turk D, Potočnik U (2020) Molecular genetic architecture of monogenic pediatric IBD differs from complex pediatric and adult IBD. J Personal Med 10:1–18. https://doi.org/10.3390/JPM10040243
Jostins L, Ripke S, Weersma RK et al (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119–124. https://doi.org/10.1038/NATURE11582
Khera AV, Chaffin M, Aragam KG et al (2018) Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 50:1219–1224. https://doi.org/10.1038/S41588-018-0183-Z
Lee JC, Biasci D, Roberts R et al (2017) Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn’s disease. Nat Genet 49:262–268. https://doi.org/10.1038/ng.3755
Lesage S, Zouali H, Cézard J-P et al (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:845–857. https://doi.org/10.1086/339432
Libioulle C, Louis E, Hansoul S et al (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 3:0538–0543. https://doi.org/10.1371/JOURNAL.PGEN.0030058
Liu JZ, Van Sommeren S, Huang H et al (2015) Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 47:979–986. https://doi.org/10.1038/NG.3359
Louis E, Michel V, Hugot JP et al (2003) Early development of stricturing or penetrating pattern in Crohn’s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 52:552–557. https://doi.org/10.1136/gut.52.4.552
Lu T, Zhou S, Wu H et al (2021) Individuals with common diseases but with a low polygenic risk score could be prioritized for rare variant screening. Genet Med off J Am College Med Genet 23:508–515. https://doi.org/10.1038/S41436-020-01007-7
Luo Y, de Lange KM, Jostins L et al (2017) Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7. Nat Genet 49:186–192. https://doi.org/10.1038/NG.3761
Magro F, Gionchetti P, Eliakim R et al (2017) Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohn’s Colitis 11:649–670. https://doi.org/10.1093/ECCO-JCC/JJX008
Martin AR, Gignoux CR, Walters RK et al (2017) Human demographic history impacts genetic risk prediction across diverse populations. Am J Hum Genet 100:635–649. https://doi.org/10.1016/J.AJHG.2017.03.004
Michailidou K (2018) Meta-analysis of common and rare variants. Methods Mole Biol (clifton, NJ) 1793:73–88. https://doi.org/10.1007/978-1-4939-7868-7_6
Newman B, Silverberg MS, Gu X et al (2004) CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn’s disease. Am J Gastroenterol 99:306–315. https://doi.org/10.1111/j.1572-0241.2004.04038.x
Ng SC, Shi HY, Hamidi N et al (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet (london, England) 390:2769–2778. https://doi.org/10.1016/S0140-6736(17)32448-0
O’Donnell S, Borowski K, Espin-Garcia O et al (2019) The unsolved link of genetic markers and crohn’s disease progression: a North American cohort experience. Inflamm Bowel Dis 25:1541–1549. https://doi.org/10.1093/ibd/izz016
Okou DT, Mondal K, Faubion WA et al (2014) Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 58:561–568. https://doi.org/10.1097/MPG.0000000000000302
Onoufriadis A, Stone K, Katsiamides A et al (2018) Exome sequencing and genotyping identify a rare variant in NLRP7 gene associated with ulcerative colitis. J Crohn’s Colitis 12:321–326. https://doi.org/10.1093/ECCO-JCC/JJX157
Orholm M, Iselius L, Sørensen TI et al (1993) Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ 306:20–24. https://doi.org/10.1136/bmj.306.6869.20
Orholm M, Munkholm P, Langholz E et al (1991) Familial occurrence of inflammatory bowel disease. N Engl J Med 324:84–88. https://doi.org/10.1056/NEJM199101103240203
Park YM, Ha E, Gu KN et al (2020) Host genetic and gut microbial signatures in familial inflammatory bowel disease. Clin Trans Gastroenterol. 11:00213
Parkes M, Barrett JC, Prescott NJ et al (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn’s disease susceptibility. Nat Genet 39:830–832. https://doi.org/10.1038/NG2061
Saint Pierre A, Génin E (2014) How important are rare variants in common disease? Brief Funct Genomics 13:353–361. https://doi.org/10.1093/BFGP/ELU025
Prescott NJ, Lehne B, Stone K et al (2015) Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes. PLoS Genet 11:1–19. https://doi.org/10.1371/JOURNAL.PGEN.1004955
Puzanowska B, Prokopowicz D, Ziarko S et al (2003) The incidence of HLA DRB1*0103 in ulcerative colitis patients in north-eastern Poland. Hepatogastroenterology 50:1436–1438
Rioux JD, Xavier RJ, Taylor KD et al (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39:596–604. https://doi.org/10.1038/NG2032
Rivas MA, Beaudoin M, Gardet A et al (2011) Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43:1066–1073. https://doi.org/10.1038/NG.952
Roussomoustakaki M, Satsangi J, Welsh K et al (1997) Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 112:1845–1853. https://doi.org/10.1053/gast.1997.v112.pm9178675
Russel RK, Satsangi J (2004) IBD: a family affair. Best Pract Res Clin Gastroenterol 18:525–539. https://doi.org/10.1016/J.BPG.2003.12.006
Sairenji T, Collins K, Evans D (2017) An update on inflammatory bowel disease. Prim Care 44:673–692. https://doi.org/10.1016/J.POP.2017.07.010
Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749–753. https://doi.org/10.1136/GUT.2005.082909
Satsangi J, Welsh KI, Bunce M et al (1996) Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347:1212–1217. https://doi.org/10.1016/s0140-6736(96)90734-5
Sazonovs A, Stevens CR, Venkataraman GR et al (2022) Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility. Nat Genet 54:1275–1283. https://doi.org/10.1038/s41588-022-01156-2
Seiderer J, Brand S, Herrmann KA et al (2006) Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn’s disease in clinical practice: results of a prospective study. Inflamm Bowel Dis 12:1114–1121. https://doi.org/10.1097/01.mib.0000235836.32176.5e
Silverberg MS, Mirea L, Bull SB et al (2003) A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease. Inflamm Bowel Dis 9:1–9. https://doi.org/10.1097/00054725-200301000-00001
Somineni HK, Nagpal S, Venkateswaran S et al (2021) Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease. Am J Hum Genet 108:431–445. https://doi.org/10.1016/J.AJHG.2021.02.001
Stittrich AB, Ashworth J, Shi M et al (2016) Genomic architecture of inflammatory bowel disease in five families with multiple affected individuals. Human Genome Variat. https://doi.org/10.1038/HGV.2015.60
Uyar FA, Imeryüz N, Saruhan-Direskeneli G et al (1998) The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey. Eur J Immunogenet 25:293–296. https://doi.org/10.1046/j.1365-2370.1998.00104.x
Venkataraman GR, Rivas MA (2019) Rare and common variant discovery in complex disease: the IBD case study. Hum Mol Genet 28:R162–R169. https://doi.org/10.1093/HMG/DDZ189
Vermeire S, Wild G, Kocher K et al (2002) CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 71:74–83. https://doi.org/10.1086/341124
Voskuil MD, Spekhorst LM, van der Sloot KWJ et al (2021) Genetic risk scores identify genetic aetiology of inflammatory bowel disease phenotypes. Journal of Crohn’s & Colitis 15:930–937. https://doi.org/10.1093/ECCO-JCC/JJAA223
Wang Q, Dhindsa RS, Carss K et al (2021) Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature 597:527–532. https://doi.org/10.1038/S41586-021-03855-Y
Weersma RK, Stokkers PCF, Van Bodegraven AA et al (2008) Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort. Gut. https://doi.org/10.1136/gut.2007.144865
Funding
This work was supported by Crohn’s and Colitis Foundation (Award number #881999).
Author information
Authors and Affiliations
Contributions
All authors contributed to the writing of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jans, D., Cleynen, I. The genetics of non-monogenic IBD. Hum Genet 142, 669–682 (2023). https://doi.org/10.1007/s00439-023-02521-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-023-02521-9